Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice.


Journal

Experimental animals
ISSN: 1881-7122
Titre abrégé: Exp Anim
Pays: Japan
ID NLM: 9604830

Informations de publication

Date de publication:
12 Nov 2020
Historique:
pubmed: 5 6 2020
medline: 24 11 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

Gender and menopause influence the severity and development manner of nonalcoholic steatohepatitis (NASH). Male p62/Sqstm1 and nuclear factor E2-related factor-2 (p62 and Nrf2) double-knockout (DKO) mice exhibit severe steatohepatitis caused by hyperphagia-induced obesity, overload of lipopolysaccharide (LPS) into the liver, and potentiation of the inflammatory response in Kupffer cells. However, the pathogenetic phenotype of steatohepatitis in female DKO mice remains unknown. Phenotypic changes of steatohepatitis in DKO mice were compared in terms of gender differences. Compared with DKO male mice, DKO female mice exhibited later onset of steatohepatitis with obesity after 30 weeks of age, as well as milder severity of hepatic inflammation and fibrosis. Serum estradiol was higher in female than male mice, with levels increasing up to 30 weeks of age before decreasing until 50 weeks of age (corresponding to the post-menopausal period). Fecal and serum LPS were lower in female mice than male mice, and inflammatory signaling in the liver was attenuated in female compared with male mice. Correlating with LPS levels, the composition of intestinal microbiota in female mice was different from male mice. Gender differences were observed for the development of steatohepatitis in DKO mice. Low-grade inflammatory hit in the liver under in vivo conditions of high estradiol may be attributable to the milder pathological features of steatohepatitis in female mice.

Identifiants

pubmed: 32493884
doi: 10.1538/expanim.20-0028
pmc: PMC7677087
doi:

Substances chimiques

Lipopolysaccharides 0
NF-E2-Related Factor 2 0
Nfe2l2 protein, mouse 0
Sequestosome-1 Protein 0
Sqstm1 protein, mouse 0
Estradiol 4TI98Z838E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-406

Références

Liver Int. 2017 Jan;37 Suppl 1:85-89
pubmed: 28052629
Hepatology. 2010 Nov;52(5):1836-46
pubmed: 21038418
Gut Microbes. 2016 Jul 3;7(4):313-322
pubmed: 27355107
Int J Obes (Lond). 2008 Jun;32(6):949-58
pubmed: 18332882
Nat Med. 2007 Jan;13(1):89-94
pubmed: 17195839
Hepatology. 2009 Jan;49(1):306-17
pubmed: 19065650
J Gastroenterol. 2012 Aug;47(8):924-35
pubmed: 22367278
Steroids. 2018 May;133:38-43
pubmed: 29100781
Gastroenterology. 2002 Jul;123(1):134-40
pubmed: 12105842
Exp Anim. 2018 May 10;67(2):201-218
pubmed: 29276215
Hepatology. 2013 Feb;57(2):601-9
pubmed: 23055155
Diabetologia. 2020 Mar;63(3):453-461
pubmed: 31754750
Sci Rep. 2017 Mar 27;7:45232
pubmed: 28345673
Gastroenterology. 2019 May;156(6):1788-1804.e13
pubmed: 30641053
PLoS One. 2013 Apr 25;8(4):e62885
pubmed: 23638162
Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
pubmed: 9240432
Cell. 2007 Dec 14;131(6):1149-63
pubmed: 18083104
Hepatology. 2016 Jul;64(1):85-91
pubmed: 26919573
Biochem Biophys Res Commun. 1996 Sep 13;226(2):456-60
pubmed: 8806656
Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):572-81
pubmed: 26663004
Cell Host Microbe. 2008 Apr 17;3(4):213-23
pubmed: 18407065
J Gastroenterol. 2013 May;48(5):620-32
pubmed: 22972520
Nat Commun. 2016 May 23;7:11624
pubmed: 27211851
J Neurosci. 2013 Sep 11;33(37):14767-77
pubmed: 24027277
Sci Rep. 2015 Oct 19;5:15224
pubmed: 26477569
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:64-70
pubmed: 24251707
Adv Enzyme Regul. 2006;46:113-40
pubmed: 16887173
Res Microbiol. 2019 Jun - Aug;170(4-5):192-201
pubmed: 30940469
Hepatology. 2012 Nov;56(5):1751-9
pubmed: 22707395
Science. 2007 Jul 6;317(5834):121-4
pubmed: 17615358
Hepatology. 2014 Apr;59(4):1406-14
pubmed: 24123276

Auteurs

Takahisa Watahiki (T)

Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Kosuke Okada (K)

Tsukuba Preventive Medicine Research Center, University of Tsukuba Hospital, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.
Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Eiji Warabi (E)

Division of Biomedical Sciences, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Tsugumi Nagaoka (T)

Division of Medical Sciences, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Hideo Suzuki (H)

Tsukuba Preventive Medicine Research Center, University of Tsukuba Hospital, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.
Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Kazunori Ishige (K)

Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Toru Yanagawa (T)

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Satoru Takahashi (S)

Division of Biomedical Sciences, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Yuji Mizokami (Y)

Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Katsutoshi Tokushige (K)

Institute of Gastroenterology and Internal Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.

Shun-Ichi Ariizumi (SI)

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.

Masakazu Yamamoto (M)

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.

Junichi Shoda (J)

Division of Medical Sciences, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH